BROOKS.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 04, 2026

Report Source: 2026 2nd Quarter Report

Brooks Laboratories Ltd

Brooks Laboratories Ltd. Stock Analysis BROOKS.NS

India Health Care Nano Cap Report:
Brooks Laboratories Ltd. operates as a research and development driven pharmaceutical manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 323 full-time employees. The company went IPO on 2011-09-02. The Company’s segment is Pharmaceutical products, including ingredients and intermediaries. The company manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, and eye/ear drops. Its products under the Carbapenem category are Imipenem 250 (Milligram) mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. The company offers Penicillins in the form of injections, tablets, and dry syrup. Its general category of products includes liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, Iron sucrose 50mg/2.5ml, Phenytoin sodium 50mg/ml and others. Its dry powder injections include Artesunate 60mg, Artesunate 120mg, Omeprazole 40mg, Rabeprazole 20mg, Pantoprazole 40mg and others.
Read More

Brooks Laboratories Ltd (BROOKS.NS) Chart

Brooks Laboratories Ltd (BROOKS.NS) vs Nifty 50 Comparative Returns

Analysis of Brooks Laboratories Ltd (BROOKS.NS) stock performance compared to the broader market (Nifty 50) across multiple timeframes.

YTD Performance
  • Brooks Laborato... (BRO...) -4.53%
  • Nifty 50 -2.73%
Brooks Laborato... Underperformed Nifty 50 by 1.80%
1Y Performance
  • Brooks Laborato... (BRO...) -43.83%
  • Nifty 50 9.8%
Brooks Laborato... Underperformed Nifty 50 by 53.63%
3Y Performance
  • Brooks Laborato... (BRO...) -20.35%
  • Nifty 50 44.11%
Brooks Laborato... Underperformed Nifty 50 by 64.46%
5Y Performance
  • Brooks Laborato... (BRO...) 31.85%
  • Nifty 50 86.54%
Brooks Laborato... Underperformed Nifty 50 by 54.69%

Key Statistics of Brooks Laboratories Ltd (BROOKS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹76.25₹82.44

Today's Open

₹77.00

Volume

142.45K

P/E Ratio (TTM)

-

52 Week Range

₹58.35₹164.02

Market Cap

1.82B

Avg. Volume

95.84K

Dividend Yield

-

Financial Metrics & Statements of Brooks Laboratories Ltd (BROOKS.NS)

Community-Curated Collections with Brooks Laboratories Ltd (BROOKS.NS) ( With BROOKS.NS )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Brooks Laboratories Ltd (BROOKS.NS)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.